simvastatin) that undergoes significant metabolism via the cytochrome P450 3A4 (CYP3A4) pathway; lovastatin and, to a lesser extent, amlodipine are also metabolized through this pathway. Several calcium channel blockers inhibit or are metabolized through the CYP3A4 pathway and can increase the risk of statin myopathy
If you want to change selection, open document below and click on "Move attachment"
pdf
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p3575
Summary
status | not read | | reprioritisations | |
---|
last reprioritisation on | | | suggested re-reading day | |
---|
started reading on | | | finished reading on | |
---|
Details